A company which has developed a clinical operating system and electronic health record has raised £6.2 million to further expand in the UK and fuel future international expansion.
Heydoc’s Series A round was led by Smedvig Capital with existing investors Hambro Perks, Triple Point Ventures and InHealth Ventures also participating.
It takes the total amount raised to date by Heydoc to $12m, with the bulk of the new raise used to grow its team, which currently stands at 30 employees.
“We’re very excited to have Smedvig Capital as a partner in this new chapter of our adventure,” said co-founder and CEO Christoph Lippuner.
“This new raise will help us accelerate our growth in the UK, focus on our product and expand its capabilities, as well as go after international markets. Innovating and contributing to a transforming healthcare industry, profoundly impacted by regulatory changes, new patient expectations and a global pandemic, is both fascinating and rewarding.
“There is so much to be done in this industry and Heydoc is barely scratching the surface.”
Heydoc’s mission is to improve healthcare by empowering clinical teams with an all-encompassing operating system. Its software solves core workflow issues for clinicians, providing a full suite of features covering both medical and administrative tasks.
Heydoc also connects its clinic customers with various other healthcare providers – such as hospital groups, pathology services and pharmacies – ensuring data liquidity and tackling a major challenge in healthcare, the lack of systems interoperability.
Since going live in 2018, it has gained rapid traction through word-of-mouth referrals and now serve thousands of clinicians and administrative staff across the UK.
Jon Lerner, MD at Smedvig Capital, added: “We are delighted to invest in Heydoc and partner with Christoph and Mikael.
“Heydoc has grown rapidly and proven that its platform can dramatically improve the way clinicians work and the quality of patient interaction.
“The company has a strong mission-based culture and a huge opportunity in front of them to be part of the future of healthcare. We’re looking forward to supporting them in achieving this goal.”